comparemela.com
Home
Live Updates
FDAs ODAC Rules Unanimously on a Faster Way to Approve Multiple Myeloma Therapies : comparemela.com
FDA's ODAC Rules Unanimously on a Faster Way to Approve Multiple Myeloma Therapies
An FDA advisory committee (ODAC) voted 12-0 today in favor of a major shift in how the agency evaluates new treatments for multiple myeloma. If approved by the
Related Keywords
Miami
,
Florida
,
United States
,
Jenny Ahlstrom
,
C Ola Landgren
,
Sean Devlin
,
Stephend Nimer
,
Sloan Kettering
,
National Cancer Institute
,
Healthtree Foundation
,
Drug Administration
,
Oncologic Drugs Advisory Committee
,
National Heart
,
International Myeloma Foundation
,
Myeloma Service
,
Memorial Sloan Kettering Cancer Center
,
Sylvester Comprehensive Cancer Center
,
University Of Miami Miller School Medicine
,
Sylvester Experimental Therapeutics Program
,
Sylvester Myeloma Research Institute
,
Oncologic Drug Advisory Committee
,
Blood Institute
,
Miami Miller School
,
Myeloma Research
,
Minimal Residual
,
Multiple Myeloma
,
Mayo Clinic
,
Experimental Therapeutics
,
Newswise
,
Ultiple Myeloma Minimal Residual Disease Odac Fdac Ola Landgren Sylvester Multiple Institute Oncologic Drugs Advisory Committee
,
comparemela.com © 2020. All Rights Reserved.